Standard Surfactants Limited Receives BSE In-Principle Approval for Preferential Issue of 8,00,000 Warrants
Standard Surfactants Limited has received BSE's in-principle approval for issuing 8,00,000 warrants convertible into equity shares of Rs. 10/- each at minimum Rs. 58/- to promoters on preferential basis. The approval, granted through letter dated March 30, 2026, enables the company to proceed with the capital raising initiative while ensuring compliance with SEBI regulations and completing post-issue formalities within specified timelines.

*this image is generated using AI for illustrative purposes only.
Standard Surfactants Limited has secured in-principle approval from BSE Limited for its proposed preferential issue of warrants convertible into equity shares. The approval marks a significant step in the company's capital raising initiative targeted at promoters.
BSE Approval Details
The company received the in-principle approval through BSE's letter bearing No. LOD/PREF/DA/FIP/1971/2025-26 dated March 30, 2026. This approval permits Standard Surfactants Limited to proceed with the proposed securities issue under the regulatory framework.
| Parameter: | Details |
|---|---|
| Regulatory Authority: | BSE Limited |
| Approval Letter No.: | LOD/PREF/DA/FIP/1971/2025-26 |
| Approval Date: | March 30, 2026 |
| Scrip Code: | 526231 |
Warrant Issue Specifications
The approved preferential issue involves specific terms for warrant conversion and pricing. The warrants are designed to provide promoters with the option to convert into equity shares at predetermined conditions.
| Specification: | Details |
|---|---|
| Number of Warrants: | 8,00,000 |
| Convertible Shares: | 8,00,000 equity shares |
| Face Value: | Rs. 10/- each |
| Minimum Price: | Rs. 58/- |
| Allottee Category: | Promoters |
| Issue Type: | Preferential basis |
Impact and Compliance Requirements
Upon receiving the in-principle approval, Standard Surfactants Limited is now permitted to issue and allot the 8,00,000 warrants convertible into equity shares to the proposed allottees. The company has fulfilled its disclosure obligations under Regulation 30 of SEBI LODR Regulations by informing the exchange about this development.
The BSE approval comes with specific compliance requirements that the company must adhere to during the issue process. These include:
- Ensuring strict compliance with Companies Act, 2013 and various SEBI regulations
- Obtaining necessary statutory and other approvals
- Strengthening internal controls to monitor trading activities
- Securing undertakings from allottees regarding trading restrictions
Post-Issue Obligations
Standard Surfactants Limited must complete several post-issue formalities following the allotment of securities. The company is required to make a listing application within twenty days from the date of allotment, as specified in SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. Non-compliance with this timeline will attract penalties as mentioned in the regulatory circular.
The BSE has reserved its right to withdraw the in-principle approval if any information submitted is found to be incomplete, incorrect, misleading, or in contravention of applicable regulations and guidelines.
Historical Stock Returns for Standard Surfactants
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
What specific business expansion or strategic initiatives will Standard Surfactants fund with the Rs. 46.4 crore raised from this warrant issue?
How might this promoter-focused capital raise affect the company's ownership structure and minority shareholder interests?
Will Standard Surfactants need to secure additional regulatory approvals beyond BSE's in-principle consent before proceeding with the warrant allotment?
































